The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

U.S health officials are updating the prescribing labels of long-acting ADHD medications to carry new warnings for children ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The approval was supported by pooled data from 2 open-label, single arm trials: the phase 2 NI-0501-06 study and the phase 3 EMERALD trial.

Tweens’ prefrontal cortex, the brain’s decision-making center, is hardly developed. These kids lack impulse control and react ...